The first case of meningitis associated with SARS-CoV-2 BA.2 variant infection with persistent viremia

Alessandra D'Abramo; Serena Vita; Francesca Colavita; Eleonora Cimini; Shalom Haggiag; Gaetano Maffongelli; Maria Beatrice Valli; Nazario Bevilacqua; Angela Corpolongo; Maria Letizia Giancola; Fabrizio Maggi; Chiara Agrati; Emanuele Nicastri

doi:10.1016/j.ijid.2022.09.011

The first case of meningitis associated with SARS-CoV-2 BA.2 variant infection with persistent viremia

Int J Infect Dis. 2022 Nov:124:38-40. doi: 10.1016/j.ijid.2022.09.011. Epub 2022 Sep 13.

Affiliations

¹ National Institute of Infectious Diseases Lazzaro Spallanzani, Institute of Hospitalization and Scientific Care, Rome, Italy.
² National Institute of Infectious Diseases Lazzaro Spallanzani, Institute of Hospitalization and Scientific Care, Rome, Italy. Electronic address: serena.vita@inmi.it.
³ Department of Neurology, San Camillo-Forlanini, Rome, Italy.

Abstract

Severe neurological disorders and vascular events during COVID-19 have been described. Here, we describe the first case of a female patient infected with the SARS-CoV-2 BA.2 Omicron variant of concern with meningitis with newly diagnosed central demyelinating disease.

Keywords: Blood barrier damage; COVID-19; Meningitis; Omicron.

Publication types

Case Reports

MeSH terms

COVID-19* / complications
Female
Humans
Meningitis*
SARS-CoV-2
Viremia / diagnosis

Supplementary concepts

SARS-CoV-2 variants